Cancer Genetics
Machine Learning Cancer Prognostic Tool Identifies MYC Gain as Glioma Drug Resistance Marker
Premium
The open-source CELLO2 algorithm helped identify a subset of glioma patients at high risk for developing resistance to Merck's Temodar (temozolomide).
Wren Labs Launches Neuroendocrine Tumor Liquid Biopsy in Asia, Works on Expanding Testing Menu
Premium
The Branford, Connecticut-based company is preparing to launch a prostate cancer liquid biopsy test while in early discussions to expand its existing test into Japan.
Pharmacotyping Links Childhood Leukemia Subtypes to Treatment Response
With drug sensitivity and genomic profiles on acute lymphoblastic leukemia cells, coupled with patient data, researchers saw pharmacotypes related to treatment response and outcomes.
Sophia Genetics Files for $100M IPO, Inks Cancer Data Deal With GE Healthcare
Sophia, which will trade on the Nasdaq, seeks to raise $100 million in an IPO, and separately announced a partnership with GE Healthcare.
Geisinger Health System Wins $3.6M NIH Grant to Study Genetics of Cancer Risk
The health system will partner with the NCI to look for new cancer risk variants in a large population biobank, in the hopes of improving screening and care.